Understanding fusion peptide mutations in influenza hemagglutinin
Understanding fusion peptide mutations in influenza hemagglutinin
批准号:
8294116
负责人:
Peter M Kasson
金额:
$28.46万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-04-01 至 2017-01-31
关键词:
AffectAntiviral AgentsAntiviral TherapyBiological AssayBiological ModelsCapsid ProteinsCell membraneCellsCessation of lifeChimeric ProteinsCoupledDataDefectDevelopmentElementsEnvironmentExperimental ModelsGoalsHemagglutininHumanInfectionInfluenzaInfluenza HemagglutininKnowledgeLaboratoriesLengthLifeLipidsMembraneMembrane FusionMembrane LipidsMethodsModelingModificationMutagenesisMutationNatureOutcomePathway interactionsPeptidesPerformancePharmaceutical PreparationsPhenotypePoint MutationProcessProteinsSterolsStructural ModelsStructureStudy modelsTestingTherapeutic AgentsUnited StatesVesicleViralVirionVirusWorkbaseinfluenzavirusmembrane assemblymolecular scalemutantnovel therapeuticspathogensimulationtheoriestherapy development
中文摘要
描述(由申请方提供):流感既是一种主要的人类病原体,在美国每年造成约50,000人死亡,也是包膜病毒进入细胞的一种经过充分研究的模型系统。流感病毒通过膜融合过程进入细胞,但尽管进行了广泛的研究,但流感病毒血凝素催化这一过程的机制尚未完全了解。实验诱变已经产生了大量的数据流感融合蛋白的功能要求,但我们没有强大的理论,可以预测这些结果。该提案旨在发展足以预测血凝素突变的融合肽机制的强大理解。我们还希望确定流感病毒进入的哪些元素是所有膜融合所共有的,因为对脂质环境的修饰也可以促进或阻断融合,并且哪些可能是病毒特异性的。我们正在开发高性能的模拟方法来分析膜融合;在这项工作中,我们将使用这些方法来预测流感融合肽的突变如何改变病毒感染细胞的能力,并研究脂质组成的变化如何与这些突变相互作用以控制病毒的感染性。计算预测将根据合作者Steinhauer实验室进行的实验测定进行评估。
公共卫生相关性:该项目研究流感外壳蛋白如何与细胞膜相互作用以感染细胞。通过研究病毒突变如何干扰这一过程,我们希望发现抗病毒治疗的新策略。
英文摘要
DESCRIPTION (provided by applicant): Influenza is both a major human pathogen, causing approximately 50,000 deaths per year in the United States and a well-studied model system for cell entry by enveloped viruses. Influenza enters cells via a process of membrane fusion, but despite extensive study the mechanism by which influenza hemagglutinin catalyzes this process is not well understood. Experimental mutagenesis has yielded much data on the functional requirements of influenza fusion proteins, but we have no robust theory that could have predicted these results. This proposal seeks to develop a robust understanding of fusion peptide mechanisms sufficient to predict such mutations to hemagglutinin. We also wish to establish which elements of influenza entry are common to all membrane fusion, as modifications to the lipid environment can also promote or block fusion, and which may be virus-specific. We are developing high-performance simulation methods to analyze membrane fusion; in this work, we will use these methods to predict how mutations to influenza fusion peptides alter the virus's ability to infect cells and to investigate how lipid composition changes interact with these mutations to control viral infectivity. Computational predictions will be evaluated against experimental assays performed in the laboratory of collaborator Steinhauer.
PUBLIC HEALTH RELEVANCE: This project studies how influenza coat proteins interact with cell membranes to infect the cell. By studying how viral mutations can interfere with this process, we hope to uncover new strategies for antiviral treatment.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Simulation-guided spectroscopy and refinement of heterogenous conformational ensembles
-
批准号:10668473
-
项目类别:
-
资助金额:$37.31万
-
财政年份:2021
-
负责人:Peter M Kasson
-
依托单位:
Simulation-guided spectroscopy and refinement of heterogenous conformational ensembles
-
批准号:10297449
-
项目类别:
-
资助金额:$39.31万
-
财政年份:2021
-
负责人:Peter M Kasson
-
依托单位:
Simulation-guided spectroscopy and refinement of heterogenous conformational ensembles
-
批准号:10494226
-
项目类别:
-
资助金额:$37.31万
-
财政年份:2021
-
负责人:Peter M Kasson
-
依托单位:
Hardening and Development of the GROMACS Molecular Simulation Engine
-
批准号:9266801
-
项目类别:
-
资助金额:$26.4万
-
财政年份:2016
-
负责人:Peter M Kasson
-
依托单位:
Hardening and Development of the GROMACS Molecular Simulation Engine
-
批准号:9103494
-
项目类别:
-
资助金额:$28.49万
-
财政年份:2016
-
负责人:Peter M Kasson
-
依托单位:
Understanding fusion peptide mutations in influenza hemagglutinin
-
批准号:8849714
-
项目类别:
-
资助金额:$5.59万
-
财政年份:2012
-
负责人:Peter M Kasson
-
依托单位:
Understanding fusion peptide mutations in influenza hemagglutinin
-
批准号:8793201
-
项目类别:
-
资助金额:$39.81万
-
财政年份:2012
-
负责人:Peter M Kasson
-
依托单位:
Understanding fusion peptide mutations in influenza hemagglutinin
-
批准号:9269426
-
项目类别:
-
资助金额:$6.2万
-
财政年份:2012
-
负责人:Peter M Kasson
-
依托单位:
Understanding fusion peptide mutations in influenza hemagglutinin
-
批准号:8449185
-
项目类别:
-
资助金额:$28.71万
-
财政年份:2012
-
负责人:Peter M Kasson
-
依托单位:
Understanding fusion peptide mutations in influenza hemagglutinin
-
批准号:8997513
-
项目类别:
-
资助金额:$34.37万
-
财政年份:2012
-
负责人:Peter M Kasson
-
依托单位:
海外基金